共 43 条
- [31] Multi-modality imaging and quantification of the effect of microtubule disrupting agent 2ME2-1198 on breast cancer progression in bone and subsequent osteolysis in a bioluminescent mouse model of metastatic bone diseaseBONE, 2010, 47 : S326 - S326Snoeks, T. J. A.Kaijzel, E. L.Cheung, H.Dijkstra, J.Lowik, C. W. G.
- [32] CCR1 Blockade by An Orally-Available CCR1 Antagonist Reduces Tumor Burden and Osteolysis In Vivo In a Mouse Model of Myeloma Bone DiseaseBLOOD, 2010, 116 (21) : 1236 - 1237Oyajobi, BabatundeDairaghi, DanielGupta, AnjanaMcCluskey, BrandonWang, YuSeitz, Lisa C.Powers, Jay P.Miao, ShichangZhang, PenglieSchall, Thomas J.Jaen, Juan C.
- [33] Novel bisphosphonate conjugates decrease metastatic bone tumor burden in the 4T1/luc mouse model of breast cancerJOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S66 - S66Reinholz, MMReinholz, GJonart, LYoneda, TSpelsberg, TLingle, WKarpeisky, M
- [34] Apo2L/tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouseCANCER RESEARCH, 2006, 66 (10) : 5363 - 5370Thai, Le MinhLabrinidis, AgathaHay, ShelleyLiapis, VasiliosBouralexis, SteveCoventry, Brendon J.Findlay, David M.Evdokiou, Andreas
- [35] Sagopilone (ZK-EPO) inhibits bone destruction and tumor burden more efficiently than paclitaxel in a mouse model of established breast cancer bone metastasisBONE, 2008, 42 : S108 - S108Strube, AnneStepina, ElizavetaKlar, UlrichHauff, PeterHoffmann, JensKaekoenen, Sanna-Maria
- [36] Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancerOncogene, 2015, 34 : 3504 - 3513H ChungY S LeeR MayoralD Y OhJ T SiuN J WebsterD D SearsJ M OlefskyL G Ellies
- [37] Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancerONCOGENE, 2015, 34 (27) : 3504 - 3513Chung, H.Lee, Y. S.Mayoral, R.Oh, D. Y.Siu, J. T.Webster, N. J.Sears, D. D.Olefsky, J. M.Ellies, L. G.
- [38] The RANKL inhibitor OPG-Fc, either alone or in combination with docetaxel, blocks lung cancer-induced osteolytic lesions and reduces skeletal tumor burden in a murine model of non-small cell lung cancer in boneBONE, 2010, 47 : S323 - S323Miller, R.Jones, J.Roudier, M.Dougall, W.
- [39] Conditional Use of Serial Serum Tumor Markers CA 15.3 and CEA as Predictors of Disease Relapse in Patients with High-Risk Early-Stage Breast CancerCANCER RESEARCH, 2024, 84 (09)Edaily, SarahSharaf, Baha'Sughayer, MaherYousef, LinaAbu-Fares, HalaAbdel-Razeq, SarahAbu-Jaish, HalaAbunasser, MahmoudKhater, SuhaibZayed, AnasEl Khatib, OsamaRahal, RahafAbdulelah, HazemShraim, MariaAbdel-Razeq, Hikmat
- [40] Rapamycin inhibits multiple stages of c-Neu/ErbB2-induced tumor progression in a transgenic mouse model of HER2-positive breast cancerMOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) : 2188 - 2197Mosley, Jonathan D.Poirier, John T.Seachrist, Darcie D.Landis, Melissa D.Keri, Ruth A.